This module features three case studies which highlight the role of nebivolol in the management of a hypertensive patient with prediabetes, a hypertensive patient with thyrotoxicosis and a history of asthma, as well as a hypertensive patient with IHD, type 2 diabetes mellitus and CHF.
This Continuous Medical Education (CME) is supported by Menarini Singapore Ptd Ltd.
You must be a member to access this content.
To become a member, please register here.
If you're already a member, please sign in to access.